Table 2.
Summary of demographic characteristics and risk status for influenza-associated morbidity and mortality (ISO weeks 40–52, dose 1)
| Belgium N = 329 | Germany N = 278 | Spain N = 453 | Overall N = 1060 | |||||
|---|---|---|---|---|---|---|---|---|
| Value or n | % | Value or n | % | Value or n | % | Value or n | % | |
| Age (year) at dose 1 vaccination | ||||||||
| Median | 68.0 | 68.5 | 6.0 | 48.0 | ||||
| Maximum | 91 | 100 | 64 | 100 | ||||
| Minimum age (month/year) at dose 1 vaccination | 23 years | 18 years | 6 months | 6 months | ||||
| Age category at dose 1 vaccination | ||||||||
| 6 months–17 years | 0 | 0.0 | 0 | 0.0 | 339 | 74.8 | 339 | 32.0 |
| 18–65 years | 133 | 40.4 | 111 | 39.9 | 114 | 25.2 | 358 | 33.8 |
| > 65 years | 196 | 59.6 | 167 | 60.1 | 0 | 0.0 | 363 | 34.2 |
| Gender | ||||||||
| Female | 147 | 44.7 | 166 | 59.7 | 231 | 51.0 | 544 | 51.3 |
| Male | 182 | 55.3 | 112 | 40.3 | 222 | 49.0 | 516 | 48.7 |
| Geographic ancestry | ||||||||
| Black or African American | 0 | 0.0 | 2 | 0.7 | 1 | 0.2 | 3 | 0.3 |
| Asian—Central/South Asian | 1 | 0.3 | 1 | 0.4 | 1 | 0.2 | 3 | 0.3 |
| Asian—East Asian | 4 | 1.2 | 1 | 0.4 | 0 | 0.0 | 5 | 0.5 |
| Asian—South East Asian | 2 | 0.6 | 0 | 0.0 | 0 | 0.0 | 2 | 0.2 |
| White—Arabic/North African | 1 | 0.3 | 0 | 0.0 | 3 | 0.7 | 4 | 0.4 |
| White—Caucasian/European | 321 | 97.6 | 274 | 98.6 | 444 | 98.0 | 1039 | 98.0 |
| Other | 0 | 0.0 | 0 | 0.0 | 4 | 0.9 | 4 | 0.4 |
| Risk status: influenza-associated morbidity and mortalitya | ||||||||
| At risk | 204 | 62.0 | 133 | 47.8 | 223 | 49.2 | 560 | 52.8 |
| Not at risk | 125 | 38.0 | 145 | 52.2 | 230 | 50.8 | 500 | 47.2 |
ISO International Standards Organization, N number of subjects vaccinated, n number and % (percentage) of vaccinated subjects in a given category
aAssessed by the HCP based on his/her judgment and experience